Tumour growth rate improves tumour assessment and first-line systemic treatment decision-making for immunotherapy in patients with liver metastatic uveal melanoma.
Br J Cancer
; 127(2): 258-267, 2022 07.
Article
in En
| MEDLINE
| ID: mdl-35347325
Full text:
1
Database:
MEDLINE
Main subject:
Neoplasms, Second Primary
/
Melanoma
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Br J Cancer
Year:
2022
Type:
Article
Affiliation country:
France